Bausch + Lomb Corp

NYSE: BLCO
$20.00
-$0.25 (-1.2%)
Closing Price on November 8, 2024

BLCO Stock Chart and Intraday Price

BLCO Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry OPHTHALMIC GOODS
Address 520 APPLEWOOD CRESCENT, VAUGHAN, ON, CA
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 5,780.84M USD
Shares Outstanding 350,992,000
Bausch + Lomb Corporation, headquartered in Vaughan, Canada, is a global leader in eye health. Founded in 1853, it offers a wide range of products across three main segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The company provides everything from contact lenses and eye care products to pharmaceuticals for treating eye conditions like glaucoma and dry eyes, as well as surgical devices and technologies for eye conditions. As a key subsidiary of Bausch Health Companies Inc., Bausch + Lomb is dedicated to addressing the full spectrum of eye health needs.

BLCO Articles

Monday's Top Analyst Upgrades and Downgrades: AMC Entertainment, Arch Resources, Lazard, Lucid, MicroStrategy, Paychex and More
Monday's top analyst upgrades and downgrades included AMC Entertainment, Arch Resources, Bausch + Lomb, Lazard, Lucid, MicroStrategy and Paychex.
Chris Lange
Published:

Thursday's Top Analyst Upgrades and Downgrades: Carvana, FedEx, First Solar, Nike, Palantir, Starbucks, Target, Workday and More
Thursday's top analyst upgrades and downgrades included Carvana, FedEx, First Solar, Generac, Nike, PagSeguro Digital, Palantir Technologies, Redfin, Regions Financial, Starbucks, Target and Workday.
Lee Jackson
Published: